Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure
Appointed director

Definitive Healthcare Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer"
08/14/2023 8-K Quarterly results
Docs: "Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023 Second quarter revenue grew 12% year-over-year to $61.0 million Framingham, MA –"
08/01/2023 8-K Quarterly results
06/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/04/2023 8-K Quarterly results
Docs: "Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2023 First quarter revenue grew 18% year-over-year to $59.2 million Framingham, MA –"
02/23/2023 8-K Quarterly results
Docs: "RE: Amendment to Executive Chairman Agreement and Employment Agreement",
"DEFINITIVE HEALTHCARE CORP. CASH INCENTIVE PLAN Effective February 16, 2023 1. Purposes of the Plan. The Plan is intended to increase stockholder value and the success of the Company by motivating Employees to perform to the best of their abilities, and achieve the Company’s objectives. 2. Definitions. “Actual Award” means, as to any Performance Period, the actual award payable to a Participant for the Performance Period, subject to the Committee’s authority under Section 3 to modify the award. “Affiliate” means any corporation or other entity controlled by the Company. “Board” means the Board of Directors of the Company. “Code” means the United States Internal Revenue Code of 1986, as amended. Reference to a specific section of the C...",
"Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022 Fourth quarter revenue grew 31% year-over-year to $60.6 million Full year 2022 revenue grew 34% to $222.7 million Framingham, MA –"
01/12/2023 8-K Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits &nbs...
Docs: "Email to Definitive Healthcare employees from Robert Musslewhite, (furnished herewith pursuant to Item 7.01)"
11/03/2022 8-K Quarterly results
10/03/2022 8-K Resignation/termination of a director
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Form of Director Restricted Stock Unit Award Agreement under 2021 Equity Incentive Plan",
"Definitive Healthcare Announces Changes to Board of Directors"
08/04/2022 8-K Quarterly results
Docs: "Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2022"
05/26/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
Docs: "Amended and Restated Employment Agreement, by and among Definitive Healthcare, LLC, Definitive Healthcare Corp. and Robert Musslewhite",
"Executive Chairman Agreement, by and among Definitive Healthcare, LLC, Definitive Healthcare Corp. and Jason Krantz",
"Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2022",
"Definitive Healthcare Names Robert Musslewhite as CEO Effective August 1, 2022"
02/23/2022 8-K Quarterly results
11/08/2021 8-K Quarterly results
Docs: "Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2021"
10/08/2021 8-K Quarterly results
10/01/2021 8-K Quarterly results
09/20/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Credit Agreement, by and among Definitive Healthcare Holdings, LLC, the lenders party thereto and the other parties specified therein and Bank of America, N.A., as administrative agent",
"Definitive Healthcare Announces Closing of Public Offering"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy